TrialReader


Hyperoxia vs Normoxia During Cardiopulmonary Bypass

NCT07510672 — Not applicable, Completed, 104 participants, University of Padova

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

Hyperoxia During Cardiopulmonary Bypass in Adult Cardiac Surgery: A Randomized Controlled Pilot Study

RegistryNCT07510672, acronym IPEROXIA
StatusCompleted
PhaseNot applicable
Study typeInterventional; randomized, parallel, masking: none, supportive care
Enrollment104 (Actual)
SponsorUniversity of Padova (Other)
ConditionsAKI, Renal Replacement Therapy, NGAL, Arrythmia, Mechanical Ventilation, Tracheostomy, Mechanical Circulatory Support, ICU Length of Stay, Hospital Length of Stay, Mortality, Surgical Complication, Cardiac Surgery
InterventionsHyperoxia group, Normoxia group (control) (Other)
Datesstart 2025-07-01, primary completion 2025-09-15, completion 2025-10-15, first posted 2026-04-03, last updated 2026-04-03
Locations1 site in Italy

Related Papers Related Patents Related Grants Related Experts
AI Assistant Save
All trials for AKI All trials for Renal Replacement Therapy All trials of Hyperoxia group All trials of Normoxia group (control)

-Summary

This single-center randomized controlled pilot trial evaluates the effects of intraoperative hyperoxia compared with normoxia during cardiopulmonary bypass (CPB) in adult patients undergoing elective cardiac surgery. The primary aim is to assess the impact on postoperative renal function. Secondary outcomes include inflammatory markers, cardiovascular and pulmonary complications, resource utilization, and short-term mortality.

Expand all sections  ·  Collapse all

+Detailed description

This monocentric randomized controlled pilot trial enrolled adult patients undergoing elective cardiac surgery requiring CPB. Participants were randomized (1:1) to receive either normoxic (PaO₂ 70-150 mmHg) or hyperoxic (PaO₂ >300 mmHg) oxygenation strategies intraoperatively.

The study evaluates postoperative renal function using eGFR, NGAL, renal replacement therapy, and KDIGO classification. Secondary outcomes include IL-6 levels, arrhythmias, mechanical circulatory support, surgical complications, ventilation duration, ICU/hospital stay, and 28-day mortality.

+Arms and interventions

ArmTypeInterventionsDescription
Normoxia groupSham comparatorOther: Normoxia group (control)Normoxia group (control): After endotracheal intubation, FiO₂ was initially set to 0.3 and subsequently adjusted to maintain PaO₂ between 70 and 150 mmHg. During CPB, air and oxygen flows through the oxygenator were titrated to maintain a target PaO₂ between 70 and 150 mmHg.
Hyperoxia groupExperimentalOther: Hyperoxia groupHyperoxia group (intervention): After endotracheal intubation, FiO₂ was maintained at 0.8 and subsequently adjusted to achieve PaO₂ above 300 mmHg. During CPB, air and oxygen flows through the oxygenator were titrated to maintain a target PaO₂ greater than 300 mmHg.
  • Hyperoxia group (Other): After endotracheal intubation, FiO₂ was maintained at 0.8 and subsequently adjusted to achieve PaO₂ above 300 mmHg. During CPB, air and oxygen flows through the oxygenator were titrated to maintain a target PaO₂ greater than 300 mmHg.
  • Normoxia group (control) (Other): After endotracheal intubation, FiO₂ was initially set to 0.3 and subsequently adjusted to maintain PaO₂ between 70 and 150 mmHg. During CPB, air and oxygen flows through the oxygenator were titrated to maintain a target PaO₂ between 70 and 150 mmHg.

+Outcome measures

Primary outcomes

  • Number of of kidney failure in adult patients undergoing to elective cardiac surgery required CPB [At 24 hours after surgery]: The renal outcomes were evaluated 24 hours after surgery, on the first postoperative day. The failure was defined according to KDIGO criteria and included estimated glomerular filtration rate (eGFR), serum Neutrophil Gelatinase-Associated Lipocalin (NGAL), and the need for postoperative renal replacement therapy.

Secondary outcomes

  • Number of patients with NGAL > 50ng/ml (index of acute kidney injury) [At 24 hours after surgery]: Serum NGAL was measured on blood sample and if NGAL: < 50 ng/mL → normal renal function 50-150 ng/mL → possible early injury 150-200 ng/mL → suggestive of AKI 400-500 ng/mL → likely AKI / moderate to severe AKI
  • Number of renal replacement therapy after surgey [Within 24 hours postoperatively]: Requirement for CRRT
  • Number of patients affected by postoperative arrhythmias [within 28 days after randomization]: Postoperative arrhythmias were defined according to AHA criteria
  • Number of patients needing extracorporeal membrane support [within 28 days after randomization]: Mechanical circulatory support requirement was defined as veno-venous support, veno-arterial support
  • Number of patients experienced surgical complications [within 28 days after randomization]: Surgical complications were defined according to Clavien-Dindo scale
  • Number of patients needing tracheostomy [within 28 days after randomization]: Tracheostomy

+Eligibility

Sex: All, ages: 18 Years to any

Inclusion Criteria:

* adult patients (>18 years old)
* need for elective cardiac surgery requiring CPB (i.e., isolated valve repair/replacement, coronary artery bypass grafting, or ascending aorta surgery)
* Time frame from July 1st to September 15th 2025

Exclusion Criteria:

* refusal of consent,
* pregnancy,
* previous Intensive Care Unit (ICU) admission,
* history of cardiac surgery requiring CPB,
* signs of preoperative cardiogenic shock (defined as requiring inotropic support, intra-aortic balloon pump, or other mechanical circulatory assistance),
* intraoperative need for circulatory arrest.

+Locations (1)

FacilityCityCountryStatus
Padova University HospitalPadova, PDItaly

My Notes